Flow cytometric analysis of Thy-1 expression in CD34-positive acute leukemia

International Journal of Hematology

Volumn 66, Issue 3, 1997, Pages 315-323

  Inaba, Tohru ^a   Shimazaki, Chihiro ^a   Sumikuma, Toshiya ^a   Takahashi, Ryoichi ^a   Hirai, Hideyo ^a   Kikuta, Takehisa ^a   Sudo, Yoshikazu ^a   Yamagata, Noboru ^a   Ashihara, Eishi ^a   Goto, Hideo ^a   Fujita, Naohisa ^a   Yoshimura, Manabu ^a   Nakagawa, Masao ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Acute leukemia; CD34; Flow cytometry; Thy 1

Indexed keywords

CD34 ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL SUBPOPULATION; COLOR ULTRASOUND FLOWMETRY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 0031258586     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(97)00051-0     Document Type: Article

References (24)

1. Reif A.E., Allen J.M. The AKR thymic antigen and its distribution in leukemias and nervous tissues. J Exp Med. 120:1964;413-433.
2. Ritter M.A., Sauvage C.A., Delia D. Human Thy-1 antigen: cell surface expression on early T and B lymphocytes. Immunology. 49:1983;555-564.
3. Craig W., Kay R., Cutler R.L., Lansdorp P.M. Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med. 177:1993;1331-1342.
4. - subpopulation from mobilized peripheral blood. Blood. 85:1995;368-378.
5. + hematopoietic cells. Blood. 85:1995;1936-1943.
6. Mayani H., Lansdorp M. Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood. Blood. 83:1994;2410-2417.
7. Lamkin T., Brooks J., Annett G., Roberts W., Weinberg K. Immunophenotypic differences between putative hematopoietic stem cells and childhood B-cell precursor acute leukemia cells. Leukemia. 8:1994;1871-1878.
8. + acute leukemia. Blood. 86:1995;60-65.
9. Pauly J.L., Minowada J., Han T., Moore G.E. Disparity of mixed lymphocyte reactivity to cultured cells of human T and B lymphoid lines. J Natl Cancer Inst. 54:1975;557-562.
10. Koeffler H.P., Golde D.W. Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. Science. 200:1978;1153-1154.
11. + hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood. 74:1989;1905-1914.
12. + myeloid progenitors: role of marrow stromal, fibroblast, and cytometrx components. Exp Hematol. 19:1991;63-70.
13. + hematopoietic cells in normal human bone marrow and leukemia. Ann Hematol. 65:1992;169-174.
14. Kroczek R.A., Gunter K.C., Seligmann B., Shevach E.M. Induction of T cell activation by monoclonal anti-Thy-1 antibodies. J Immunol. 136:1986;4379-4384.
15. 2+ independent mechanism. J Exp Med. 173:1991;515-518.
16. Borowitz M.J., Gockerman J.P., Moore J.O.et al. Clinicopathologic and cytogenic features of CD34(My10)-positive acute nonlymphocytic leukemia. Am J Clin Pathol. 91:1989;265-270.
17. Geller R.B., Zahurak M., Hurwitz C.A.et al. Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My10). Br J Haematol. 76:1990;340-347.
18. Kessinger A., Armitage J.O., Landmark J.D., Smith D.M., Weisenburger D.D. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood. 71:1988;723-727.
19. Kessinger A., Armitage J.O., Smith D.M., Landmark J.D., Bierman P.J., Weisenburger D.D. High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood. 74:1989;1260-1265.
20. Shimazaki C., Oku N., Ashihara E.et al. Collection of peripheral blood stem cells mobilized by high-dose Ara-C plus VP-16 or aclarubicin followed by recombinant human granulocyte-colony stimulating factor. Bone Marrow Transplant. 10:1992;341-346.
21. Gribben J.G., Freedman A.S., Neuberg D.et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. New Engl J Med. 325:1991;1523-1533.
22. + marrow cells in patients with breast cancer or neuroblastoma. Blood. 77:1991;1717-1722.
23. + positive peripheral blood progenitors and growth factors on engraftment. J Clin Oncol. 12:1994;28-36.
24. + human bone marrow hematopoietic cells with high recovery of early progenitors. Exp Hematol. 23:1995;407-412.